In contrast to recent guidelines, the majority of the intervention trials conducted on the topic till date found a promising role of ICD only in the prevention of SCD in NYHA class II HF. One of the trials which found a significant role of ICD in type III heart failure was underpowered. ...
浙江大学硕士学位论文心脏再同步化治疗NYHAI/II级心力衰竭患者的疗效Meta分析姓名:***请学位级别:硕士专业:心血管学指导教师:**香20120517浙江大学硕士学位论文中文摘要心脏再同步化治疗NYHAI/II级心力衰竭患者的疗效Meta分析中文摘要目的通过Meta分析来评价心脏再同步化治疗对NⅥ{AI/II级、左室射血分数下降、宽QRs...
doi:10.1056/NEJMoa1009540MyrvangHeleneNature Reviews CardiologyMyrvang, H., 2011. Device therapy: Adding CRT to ICD improves outcomes in patients with NYHA class II and III heart failure. Nature Reviews. Cardiology, 8(1), p.4.
Results reveal that 19.5 percent of patients within the ICD-CRT group were admitted to the hospital, lower than 26.1 percent in the ICD group.MyrvangHeleneEBSCO_AspNature Reviews CardiologyMyrvang, H., 2011. Device therapy: Adding CRT to ICD improves outcomes in patients with NYHA class II and...
Device therapy: Adding CRT to ICD improves outcomes in patients with NYHA class II and III heart failureNature Reviews Cardiology 8, 4 (2011). doi:10.1038/nrcardio.2010.194Author: Helene M ...doi:10.1038/nrcardio.2010.194MyrvangHeleneNature Reviews Cardiology...